Chairman\'s Letter - General Meeting Invitation
Filed with Euronext · · 3 pages · English
Earlier from Biophytis
- Biophytis S A ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
- Biophytis S A to evaluate BIO101’s potential to limit weight regain in its OBA clinical study in obesity
- Biophytis S A strengthens its financial position and extends its cash runway into Q1 2027
- Biophytis S A PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
- Information on annual financial statements
Follow Biophytis into a list and get an email when it puts out news.
Follow Biophytis